Business Wire

Zev Marynberg Reveals to Bloomberg the Investment Keys of Its Top Performing Adar Macro Fund in 2017

10.3.2017 14:10 | Business Wire

Del

Zev Marynberg, Founder and CIO of the hedge fund Adar Macro Fund, one of the top performing hedge funds of 2016 with a 33.5 percent return on investment in 2016, reveals in an interview with Bloomberg his investment strategy for 2017. “We invest mainly in Latin America and Europe. We look for undervalued assets, mainly fixed income securities issued by sovereign or quasi-sovereign issuers, in countries where we believe macroeconomic changes will occur. We perform only fundamental analysis and visit each of the places where we invest. Our main focus is on securities issued or backed by nations or states. A sovereign issuer may have to restructure, but given sufficient resources and time, would be able to repay its debts. Corporations can disappear, as happened with Lehman Brothers. We don’t want to take that risk for our investors”.

Brazil, Colombia and Venezuelan bonds contributed to the fund’s great performance in 2016. Marynberg thinks there are great opportunities in the areas Adar Macro Fund focuses on. “We don’t look for 20 assets; we look for five to ten ideas. Still, some assets are very undervalued and some yields are well above U.S. Treasury yields, with very attractive coupons.”

“In 2017 Adar Macro Fund took profits in Colombia because our investments matured. We added assets in Argentina, since we believe the economy will begin to grow, as well as in Portugal, since some quasi-sovereign fixed-income securities trade with a spread of 400 over sovereign,” says Zev Marynberg.

Concerning its strategy for 2017, Zev Marynberg comments: “In the first place we have a current yield above 8 percent per annum. Some of our investment opportunities may mature sooner rather than later because the macroeconomic indicators in those countries are already improving. You can never predict a day for a capital appreciation to occur, but it’s certain that over time, distortions in undervalued assets will disappear.”

We like sovereigns; they are liquid, have good payment capacity and will never disappear, at least not in our lifetimes. In currencies, we like the U.S. dollar. We are optimistic that President Trump is pragmatic, has experience and will take the measures the U.S. economy needs in order to grow more. Over 85 percent of our investment is in the U.S. dollar. We reduced duration in our portfolio since interest rates have only one direction to go, and that’s up,” said Marynberg.

On the rise of populism in Europe, the CIO of Adar Macro Fund stated: “We are overweight in Germany. REITs dedicated to eastern Germany are still trading very cheap, cheaper than the rest of Germany, Europe and even South America. You still can buy the best offer space in Berlin at a discount with respect to Mexico City, Buenos Aires and even Caracas, Venezuela. In Portugal, fixed-income markets still have good opportunities.”

Adar Macro Fund

Adar Macro Fund is a hedge fund managed by Adar Capital Partners. Founded in 2011, Adar Capital Partners Ltd. provides investment advice to institutions, family offices and private equity funds, mainly in Latin America and Europe. It currently manages total assets in excess of $1.5 billion. In 2016 Adar Macro Fund obtained the awards "Best Latin America Emerging Markets Fund 3 Years" by Acquisition International and "Most Innovative Hedge Fund of the Year 2016" according to the magazine Wealth & Finance. Ticker Bloomberg: ADARMAA KY.

http://www.adarcapitalpartners.com

Contact information

Media:
Newsline
Miguel Ramos
mramos@newsline-pr.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom